Lab trials prove copper therapy enhances cognitive function and spatial learning - News-Medical — Live Feedhttps://www.live-feeds.com/feed/lab-trials-prove-copper-therapy-enhances-cognitive-function-and-spatial-learning-news-medicalContinuously updated, source-cited coverage. Copper therapy shows promise in Alzheimer’s trials, cutting toxic proteins and restoring memoryhttps://www.live-feeds.com/feed/lab-trials-prove-copper-therapy-enhances-cognitive-function-and-spatial-learning-news-medicalhttps://www.live-feeds.com/feed/lab-trials-prove-copper-therapy-enhances-cognitive-function-and-spatial-learning-news-medical#u1596Tue, 16 Jun 2026 19:16:28 +0000Preclinical studies confirm a copper-delivering drug reduces Alzheimer’s toxic proteins by up to 42% and improves spatial memory in lab models. Researchers say the compound restores brain clearance mechanisms and may accelerate human trials due to prior safety testing. No human data exists yet, but the findings mark a shift in potential treatment strategies.What's confirmed:A copper-based compound called Cu(ATSM) reduced toxic Alzheimer’s proteins by 42% in laboratory experiments.The same drug improved spatial memory by 44% in Alzheimer’s disease models by restoring blood-brain barrier clearan